ANSYS INC (AKX.DE) Fundamental Analysis & Valuation

FRA:AKX • US03662Q1058

Current stock price

270.9 EUR
-6.5 (-2.34%)
Last:

This AKX.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. AKX.DE Profitability Analysis

1.1 Basic Checks

  • AKX had positive earnings in the past year.
AKX.DE Yearly Net Income VS EBIT VS OCF VS FCFAKX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M 500M

1.2 Ratios

Industry RankSector Rank
ROA 7.49%
ROE 10.29%
ROIC 8.9%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AKX.DE Yearly ROA, ROE, ROICAKX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 5 10 15

1.3 Margins

Industry RankSector Rank
OM 27.84%
PM (TTM) 22.96%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AKX.DE Yearly Profit, Operating, Gross MarginsAKX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 20 40 60 80

4

2. AKX.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AKX is destroying value.
  • AKX has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, AKX has an improved debt to assets ratio.
AKX.DE Yearly Shares OutstandingAKX.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M
AKX.DE Yearly Total Debt VS Total AssetsAKX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2B 4B 6B

2.2 Solvency

  • AKX has an Altman-Z score of 10.27. This indicates that AKX is financially healthy and has little risk of bankruptcy at the moment.
  • AKX has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 10.27
ROIC/WACC0.83
WACC10.69%
AKX.DE Yearly LT Debt VS Equity VS FCFAKX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 2.12 indicates that AKX has no problem at all paying its short term obligations.
  • AKX has a Quick Ratio of 2.12. This indicates that AKX is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 2.12
AKX.DE Yearly Current Assets VS Current LiabilitesAKX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

5

3. AKX.DE Growth Analysis

3.1 Past

  • AKX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.29%.
  • AKX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.22% yearly.
  • The Revenue has grown by 10.84% in the past year. This is quite good.
  • The Revenue has been growing by 14.04% on average over the past years. This is quite good.
EPS 1Y (TTM)3.29%
EPS 3Y7.16%
EPS 5Y15.22%
EPS Q2Q%-4.32%
Revenue 1Y (TTM)10.84%
Revenue growth 3Y13.81%
Revenue growth 5Y14.04%
Sales Q2Q%6.09%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.11% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 8.24% on average over the next years. This is quite good.
EPS Next Y7.19%
EPS Next 2Y8.57%
EPS Next 3Y9.15%
EPS Next 5Y9.11%
Revenue Next Year6.93%
Revenue Next 2Y8.03%
Revenue Next 3Y8.38%
Revenue Next 5Y8.24%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AKX.DE Yearly Revenue VS EstimatesAKX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B
AKX.DE Yearly EPS VS EstimatesAKX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8 10

0

4. AKX.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • AKX is valuated quite expensively with a Price/Earnings ratio of 36.02.
  • AKX is valuated rather expensively when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 31.20, AKX can be considered very expensive at the moment.
  • When comparing the Price/Forward Earnings ratio of AKX to the average of the S&P500 Index (38.20), we can say AKX is valued inline with the index average.
Industry RankSector Rank
PE 36.02
Fwd PE 31.2
AKX.DE Price Earnings VS Forward Price EarningsAKX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 35.77
AKX.DE Per share dataAKX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AKX does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)5.01
PEG (5Y)2.37
EPS Next 2Y8.57%
EPS Next 3Y9.15%

0

5. AKX.DE Dividend Analysis

5.1 Amount

  • AKX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AKX.DE Fundamentals: All Metrics, Ratios and Statistics

ANSYS INC

FRA:AKX (8/19/2022, 7:00:00 PM)

270.9

-6.5 (-2.34%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.59B
Revenue(TTM)2.00B
Net Income(TTM)458.30M
Analysts72.8
Price Target315.38 (16.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 36.02
Fwd PE 31.2
P/S 11.83
P/FCF N/A
P/OCF N/A
P/B 5.3
P/tB N/A
EV/EBITDA 35.77
EPS(TTM)7.52
EY2.78%
EPS(NY)8.68
Fwd EY3.2%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS22.91
BVpS51.1
TBVpSN/A
PEG (NY)5.01
PEG (5Y)2.37
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 7.49%
ROE 10.29%
ROCE N/A
ROIC 8.9%
ROICexc N/A
ROICexgc 42.33%
OM 27.84%
PM (TTM) 22.96%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.12
Quick Ratio 2.12
Altman-Z 10.27
F-Score7
WACC10.69%
ROIC/WACC0.83
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.29%
EPS 3Y7.16%
EPS 5Y15.22%
EPS Q2Q%-4.32%
EPS Next Y7.19%
EPS Next 2Y8.57%
EPS Next 3Y9.15%
EPS Next 5Y9.11%
Revenue 1Y (TTM)10.84%
Revenue growth 3Y13.81%
Revenue growth 5Y14.04%
Sales Q2Q%6.09%
Revenue Next Year6.93%
Revenue Next 2Y8.03%
Revenue Next 3Y8.38%
Revenue Next 5Y8.24%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

ANSYS INC / AKX.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ANSYS INC (AKX.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to AKX.DE.


What is the valuation status for AKX stock?

ChartMill assigns a valuation rating of 0 / 10 to ANSYS INC (AKX.DE). This can be considered as Overvalued.


What is the profitability of AKX stock?

ANSYS INC (AKX.DE) has a profitability rating of 6 / 10.


What is the valuation of ANSYS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ANSYS INC (AKX.DE) is 36.02 and the Price/Book (PB) ratio is 5.3.


What is the financial health of ANSYS INC (AKX.DE) stock?

The financial health rating of ANSYS INC (AKX.DE) is 9 / 10.